Presence of secretory group IIa and V phospholipase A2 and cytosolic group IVα phospholipase A2 in chondrocytes from patients with rheumatoid arthritis
-
Abstract
Both secretory and cytosolic phospholipase A2 enzymes have been implicated in the pathogenesis of arthritis in animal models, but the exact expression patterns of the enzymes in diseased human joint tissue are uncertain. We investigated the messenger RNA expression of group IIa, IVα and V phospholipase A2 and localized the presence of group IIa and IVα phospholipase A2 at protein levels in articular cartilage from patients with rheumatoid arthritis, osteoarthritis and patients with non-arthritic joints. Both group IIa phospholipase A2 messenger RNA and protein were detected in all samples independent of diagnosis, but were far more prominent in cartilage from rheumatoid arthritis samples. In cartilage with rheumatoid arthritis, the enzyme was detected both within the chondrocytes and in the extracellular matrix, whereas only few osteoarthritic cartilage samples showed positive staining in the matrix. In the cartilage matrix of non-arthritic controls, group IIa phospholipase A2 was totally absent. Messenger RNA for the group IVα and V phospholipase A2 was, except for one osteoarthritic cartilage sample, exclusively detected in rheumatoid arthritic cartilage. For group IVα phospholipase A2 this was also confirmed at the protein level. These results suggest that each phospholipase A2 enzyme has distinct roles in both healthy and diseased joint tissue, and that the diversity and amount of enzyme correlate with the grade of inflammation and disease severity.
Copyright © 2004 by Walter de Gruyter GmbH & Co. KG
Articles in the same Issue
- Publishers note
- Towards quality specifications in extra-analytical phases of laboratory activity
- Quality indicators and specifications for the extra-analytical phases in clinical laboratory management
- Pitfalls and drawbacks in screening of congenital disorders of glycosylation
- Activity of eosinophils and immunoglobulin E concentration in the peritoneal fluid of women with endometriosis
- Rapid generation of detailed loss of heterozygosity profiles for routine diagnosis of gliomas
- Presence of secretory group IIa and V phospholipase A2 and cytosolic group IVα phospholipase A2 in chondrocytes from patients with rheumatoid arthritis
- Neurokinin B levels in maternal circulation during early pregnancy
- Cl- regulates cryoglobulin structure: a new hypothesis for the physiopathological mechanism of temperature non-dependent cryoprecipitation
- Urine labeling with orally applied marker substances in drug substitution therapy
- Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure
- Clinical utility of serum holotranscobalamin as a marker of cobalamin status in elderly patients with neuropsychiatric symptoms
- Comparison of serum creatinine, uric acid, albumin and glucose in male professional endurance athletes compared with healthy controls
- Low S-adenosylmethionine concentrations found in patients with severe inflammatory bowel disease
- Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3)
- The influence of freezer storage of urine samples on the BONN-Risk-Index for calcium oxalate crystallization
- First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay – Lp(a) SRM 2B
- Myeloma cells produce sialyl salivary-type amylase
- Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors
- Meetings and Awards
Articles in the same Issue
- Publishers note
- Towards quality specifications in extra-analytical phases of laboratory activity
- Quality indicators and specifications for the extra-analytical phases in clinical laboratory management
- Pitfalls and drawbacks in screening of congenital disorders of glycosylation
- Activity of eosinophils and immunoglobulin E concentration in the peritoneal fluid of women with endometriosis
- Rapid generation of detailed loss of heterozygosity profiles for routine diagnosis of gliomas
- Presence of secretory group IIa and V phospholipase A2 and cytosolic group IVα phospholipase A2 in chondrocytes from patients with rheumatoid arthritis
- Neurokinin B levels in maternal circulation during early pregnancy
- Cl- regulates cryoglobulin structure: a new hypothesis for the physiopathological mechanism of temperature non-dependent cryoprecipitation
- Urine labeling with orally applied marker substances in drug substitution therapy
- Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure
- Clinical utility of serum holotranscobalamin as a marker of cobalamin status in elderly patients with neuropsychiatric symptoms
- Comparison of serum creatinine, uric acid, albumin and glucose in male professional endurance athletes compared with healthy controls
- Low S-adenosylmethionine concentrations found in patients with severe inflammatory bowel disease
- Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3)
- The influence of freezer storage of urine samples on the BONN-Risk-Index for calcium oxalate crystallization
- First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay – Lp(a) SRM 2B
- Myeloma cells produce sialyl salivary-type amylase
- Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors
- Meetings and Awards
